ArticleBMC cancer2022

Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status.

Tetsuya Isaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.